nifedipine and quinoxalines

Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Calcium; Calcium Channels; Egtazic Acid; Electric Stimulation; Evoked Potentials; Guinea Pigs; Hippocampus; In Vitro Techniques; Kinetics; Male; Nifedipine; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptic Transmission; Time Factors

Topics: Analysis of Variance; Animals; Aspartate Aminotransferases; Cells, Cultured; Cerebral Cortex; Cycloheximide; Dactinomycin; Dizocilpine Maleate; Dose-Response Relationship, Drug; Kinetics; Magnesium; N-Methylaspartate; Neurons; Nifedipine; Potassium; Quinoxalines; Rats; Tetrodotoxin

Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Calcium; Calcium Channels; Cerebellar Cortex; Cycloleucine; Diltiazem; Glutaminase; Ibotenic Acid; Ion Channel Gating; L-Lactate Dehydrogenase; Neuronal Plasticity; Neurons; Nifedipine; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, AMPA; Receptors, Neurotransmitter

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Azepines; Blood Pressure; Brimonidine Tartrate; Cardiac Output; Cats; Dinoprost; Dioxanes; Electric Stimulation; Female; Idazoxan; Male; Methoxamine; Nifedipine; Nisoldipine; Norepinephrine; Phenylephrine; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Quinoxalines; Splanchnic Circulation; Sulfonamides; Sympathetic Nervous System; Tyramine; Vascular Resistance; Vasoconstriction

Topics: Adrenergic alpha-Antagonists; Animals; Benzazepines; Brimonidine Tartrate; Dogs; Guinea Pigs; Male; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Quinoxalines; Rats; Rats, Inbred Strains; Serotonin; Synaptic Transmission; Vasoconstriction

Topics: Animals; Bicuculline; Calcium Channels; Cells, Cultured; gamma-Aminobutyric Acid; Glutamic Acid; Nifedipine; Nitrendipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptides; Quinoxalines; Rats; Retinal Ganglion Cells; Spider Venoms; Synaptic Transmission; Thy-1 Antigens

Topics: Animals; Arginine; Calcium; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Cyclic GMP; Dantrolene; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fetus; Glutamates; Glutamic Acid; Hemoglobins; HIV Envelope Protein gp120; HIV-1; Inositol Phosphates; Models, Neurological; Neurons; Neurotoxins; Nifedipine; Nitric Oxide; Nitroarginine; Quinoxalines; Rats

Topics: Administration, Oral; Adrenergic alpha-Agonists; Animals; Blood Pressure; Brimonidine Tartrate; Calcium Channel Blockers; Decerebrate State; Dihydropyridines; Electric Stimulation; Nifedipine; Norepinephrine; Phenylephrine; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Spinal Cord; Sympathetic Nervous System

Topics: 2-Amino-5-phosphonovalerate; Animals; Bicuculline; gamma-Aminobutyric Acid; In Vitro Techniques; Long-Term Potentiation; Motor Cortex; Neurons; Nifedipine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Somatosensory Cortex; Synapses; Synaptic Transmission

Topics: Action Potentials; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Dogs; Female; Heart; Male; Nifedipine; Purkinje Cells; Quinoxalines; Receptors, Adrenergic, alpha-2

Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Blood Pressure; Brimonidine Tartrate; Calcium; Calcium Channel Blockers; Clonidine; Diabetes Mellitus, Experimental; Hypertension; Imidazoles; Nifedipine; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Streptozocin

Topics: Adenosine Triphosphate; Animals; Apamin; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Intestines; Male; Neurotransmitter Agents; Nifedipine; Nitric Oxide; Nitroarginine; Nitroprusside; Oxadiazoles; Oxyhemoglobins; Quinoxalines

Topics: 2-Amino-5-phosphonovalerate; Animals; Axons; Calcium; Calcium Channel Blockers; Calcium Channels; Dendrites; Excitatory Postsynaptic Potentials; Glycine; In Vitro Techniques; Models, Neurological; Nifedipine; Olfactory Bulb; omega-Conotoxin GVIA; omega-Conotoxins; Patch-Clamp Techniques; Peptides; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Synapses; Synaptic Transmission; Tetrodotoxin

Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Benzoates; Calcium; Cells, Cultured; Dizocilpine Maleate; Egtazic Acid; Epilepsy; Excitatory Amino Acid Antagonists; Glycine; Hippocampus; Magnesium; Membrane Potentials; Microscopy, Confocal; Neurons; Nifedipine; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Signal Transduction

Topics: Animals; Aorta, Thoracic; Binding, Competitive; Calcium Channel Blockers; Cerebral Cortex; Dihydropyridines; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Male; Methylene Blue; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Nitric Oxide Donors; Oxadiazoles; Quinoxalines; Radioligand Assay; Rats; Rats, Wistar; Structure-Activity Relationship; Vasodilator Agents

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Animals; Caffeine; Calcium Channel Blockers; Cyclic GMP; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Gastric Fundus; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Muscle Relaxation; Muscle, Smooth; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Oxadiazoles; Quinoxalines; Ryanodine

Topics: 2-Amino-5-phosphonovalerate; Action Potentials; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autoreceptors; Bicuculline; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; GABA Antagonists; Glutamic Acid; In Vitro Techniques; Neurons, Afferent; Nifedipine; Olfactory Bulb; Patch-Clamp Techniques; Picrotoxin; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Tetrodotoxin

Topics: Calcium Channels; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Humans; In Vitro Techniques; Nifedipine; Nitric Oxide; Nitroprusside; Oxadiazoles; Oxygen; Potassium; Potassium Channel Blockers; Potassium Channels; Quinoxalines; Receptors, Atrial Natriuretic Factor; Umbilical Arteries; Vasodilation; Vasodilator Agents

Topics: Animals; Cell Death; Cells, Cultured; Cerebral Cortex; Cyclosporine; Dizocilpine Maleate; Egtazic Acid; Embryo, Mammalian; Excitatory Amino Acid Antagonists; Glutamic Acid; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neurons; Nifedipine; Okadaic Acid; Phosphoprotein Phosphatases; Protein Kinases; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Butadienes; Calcium-Calmodulin-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Forelimb; Genistein; Isoflavones; Mitogen-Activated Protein Kinases; Nifedipine; Nitriles; Potassium Chloride; Quinoxalines; Receptors, Adrenergic, alpha-2; Signal Transduction; Swine; Vasoconstriction; Vasodilator Agents; Veins; Verapamil

Topics: Animals; Apamin; Atropine; Calcium Channels; Charybdotoxin; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Ileum; Molsidomine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nifedipine; Nitric Oxide; Nitroprusside; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Tetraethylammonium; Tetrodotoxin

Topics: 2-Amino-5-phosphonovalerate; Animals; Anti-Anxiety Agents; Brain; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Chick Embryo; Down-Regulation; Excitatory Amino Acid Antagonists; Flunitrazepam; gamma-Aminobutyric Acid; Membrane Potentials; Neurons; Nifedipine; Potassium; Quinoxalines; Receptors, GABA-A; Signal Transduction; Tetrodotoxin; Tritium

Topics: Anesthetics, Local; Animals; Calcium Channel Blockers; Cyclic GMP; Enzyme Inhibitors; Esophagus; Female; In Vitro Techniques; Isometric Contraction; Male; Microelectrodes; Muscle, Smooth; Nifedipine; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Opossums; Oxadiazoles; Quinoxalines; Signal Transduction; Tetrodotoxin; Triazenes

Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Animals; Calcium; Calcium Channel Blockers; Chelating Agents; Egtazic Acid; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Neurons; Nifedipine; Organ Culture Techniques; Potassium Channel Blockers; Quinoxalines; Rats; Rats, Sprague-Dawley; Subthalamic Nucleus; Temperature; Tetraethylammonium; Tetrodotoxin

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Brimonidine Tartrate; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Enzyme Inhibitors; Hypertension; Male; Muscle, Smooth, Vascular; Nifedipine; Nitric Oxide Synthase; Nitroarginine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Vasoconstriction

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Colon; Dogs; Electric Conductivity; Enteric Nervous System; Enzyme Inhibitors; Female; Gastrointestinal Motility; In Vitro Techniques; Indoles; Male; Membrane Potentials; Mitochondria; Muscle, Smooth; Nickel; Nifedipine; Nitric Oxide; Nitric Oxide Donors; Nitroarginine; Nitroprusside; Oxadiazoles; Potassium; Quinoxalines; Uncoupling Agents

Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels, L-Type; Cytoplasm; Excitatory Amino Acid Antagonists; Hippocampus; I-kappa B Proteins; Ketamine; Male; NF-kappa B; Nifedipine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Amino Acid; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Time Factors

Topics: Animals; Brain Ischemia; Calcium Channels, L-Type; Gerbillinae; Hippocampus; Ketamine; Nifedipine; Phosphorylation; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Synaptosomes; Tyrosine

Topics: Animals; Apoptosis; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Culture Techniques; Cell Survival; Diltiazem; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Neuroprotective Agents; Nifedipine; Quinoxalines; Rats; Receptors, AMPA; Receptors, Kainic Acid; Retinal Ganglion Cells

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Brain; Cadmium; Calcium Channel Blockers; Calcium Channels, L-Type; Egtazic Acid; In Vitro Techniques; Kinetics; Male; Neurotransmitter Agents; Nifedipine; Quinoxalines; Rats; Rats, Sprague-Dawley; Thapsigargin

Topics: Acetylcysteine; Animals; Brain Ischemia; Calcium Channel Blockers; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Immunoblotting; Ketamine; Male; Mitogen-Activated Protein Kinase 10; Mitogen-Activated Protein Kinases; Nifedipine; Protein Transport; Protein-Tyrosine Kinases; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Time Factors

Topics: Animals; Anthracenes; Atropine; Azepines; Caffeine; Calcium; Chloride Channels; Enzyme Inhibitors; Esophagogastric Junction; Female; Guanethidine; In Vitro Techniques; Indoles; Male; Membrane Potentials; Muscle, Smooth; Myosin-Light-Chain Kinase; Nifedipine; Niflumic Acid; Nitric Oxide; Opossums; Oxadiazoles; Quinoxalines; Ryanodine; Sarcoplasmic Reticulum; Substance P; Tetraethylammonium

Topics: Animals; Aorta, Thoracic; Asteraceae; Brazil; Diterpenes; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethanol; Indomethacin; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nifedipine; Oxadiazoles; Phenylephrine; Plant Extracts; Plant Roots; Quinoxalines; Rats; Rats, Wistar; Tetraethylammonium; Vasoconstriction; Vasodilation

Topics: Alkaloids; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzophenanthridines; Biotinylation; Blotting, Western; Brain; Brefeldin A; Calcium Channel Blockers; Cell Adhesion; Cells, Cultured; Chlorocebus aethiops; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation; Glycine; In Vitro Techniques; Integrin alphaVbeta3; Mitogen-Activated Protein Kinase Kinases; Neurons; Nifedipine; Paxillin; Phenanthridines; Phosphoproteins; Protein Synthesis Inhibitors; Protein-Tyrosine Kinases; Quinoxalines; Rats; Receptors, AMPA; src-Family Kinases; Time Factors; Transfection; Valine

Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Carotid Stenosis; Enzyme Activation; Hippocampus; Ischemic Attack, Transient; JNK Mitogen-Activated Protein Kinases; Ketamine; Male; Nifedipine; Phosphorylation; Protein Binding; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Reperfusion; Transcription Factor AP-1

Topics: Acetylcholine; Animals; Anions; Antioxidants; Calcitonin Gene-Related Peptide; Coronary Vessels; Dose-Response Relationship, Drug; Guanylate Cyclase; Heart Rate; Isoproterenol; Male; Myocardial Contraction; Nifedipine; Nitrites; Nitrogen Oxides; Oxadiazoles; Oxidation-Reduction; Peptide Fragments; Perfusion; Potassium; Quinoxalines; Rats; Rats, Sprague-Dawley; Sodium Nitrite; Vasodilation

Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Dizocilpine Maleate; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Formazans; Glucose; Hypoxia; Mice; N-Methylaspartate; Neurons; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Quinoxalines; Receptors, Kainic Acid; Reperfusion Injury; Tetrazolium Salts; Time Factors

Topics: Age Factors; Animals; Animals, Newborn; Bicuculline; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Movement; Cerebral Cortex; Electroporation; Embryo, Mammalian; Female; GABA Agents; gamma-Aminobutyric Acid; Gene Expression Regulation; Glutamic Acid; Green Fluorescent Proteins; Homeodomain Proteins; Interneurons; K Cl- Cotransporters; LIM-Homeodomain Proteins; Membrane Potentials; Mice; Mice, Inbred BALB C; Mice, Transgenic; Microtubule-Associated Proteins; Models, Biological; Muscimol; Nerve Tissue Proteins; Nifedipine; omega-Conotoxin GVIA; Organ Culture Techniques; Pregnancy; Quinoxalines; Receptors, N-Methyl-D-Aspartate; RNA, Small Interfering; Sequence Deletion; Symporters; Transcription Factors; Valine

Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels; Excitatory Amino Acid Antagonists; Gerbillinae; Hippocampus; Ketamine; Nifedipine; Phosphorylation; Phosphotyrosine; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury

Topics: 4-Aminopyridine; Adenine; Aminoglutethimide; Androgen Receptor Antagonists; Animals; Aromatase Inhibitors; Barium Compounds; Basilar Artery; Calcium Channel Blockers; Calcium Channels; Chlorides; Cycloheximide; Dactinomycin; Dogs; Enzyme Inhibitors; Flutamide; In Vitro Techniques; Male; Nifedipine; Nucleic Acid Synthesis Inhibitors; Oxadiazoles; Potassium Channel Blockers; Potassium Channels; Protein Synthesis Inhibitors; Quinoxalines; Testosterone; Vasodilation; Vasodilator Agents

Topics: Animals; Aorta, Thoracic; Cells, Cultured; Cinnamates; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Male; Myocytes, Smooth Muscle; Nifedipine; Phenylephrine; Quinoxalines; Rats; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; RNA, Messenger; Thapsigargin; Vasoconstriction; Vasoconstrictor Agents

Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic GMP; Cysteine; Diltiazem; Female; Femoral Artery; Fetus; Indazoles; Male; Mesenteric Arteries; Nifedipine; Oxadiazoles; Quinoxalines; S-Nitrosoglutathione; S-Nitrosothiols; Sheep; Soluble Guanylyl Cyclase; Vasodilation; Vasodilator Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Benzothiadiazines; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Dipeptides; Excitatory Postsynaptic Potentials; Female; Gerbillinae; Hair Cells, Vestibular; Male; Nifedipine; Quinoxalines; Receptors, AMPA; Strontium; Synapses